The CEO of Darnytsia Held a Bilateral Meeting with the Chargé d’Affaires a.i. of the Republic of Iraq to Ukraine, Minister Plenipotentiary
The CEO of Darnytsia Pharmaceutical Company Andrii Obrizan held a bilateral meeting with the the Chargé d’Affaires a.i. of the Republic of Iraq to Ukraine, Minister Plenipotentiary Mr. Tarek Adil Kazem.
During the meeting, the parties discussed the possibilities of continuing and expanding cooperation. In particular, increasing the presence of Darnytsia medicines in the market of the Republic of Iraq. Andrii Obrizan talked about the priorities of the company’s work in the conditions of a full-scale war. Today, Darnytsia medicines are indispensable in cardiology, neurology and pain management in Ukraine and abroad.
The company also continues to focus on innovation. Darnytsia develops complex generics, creates new sales models, digitizes its activities, offering services with added value for patients and doctors.
Despite the full-scale war, Darnytsia continues to expand the geography of drug sales markets. Thus, today Darnytsia medicines are presented in 17 countries of the world, in addition to Ukraine. Iraq is an important partner, cooperation with which Darnytsia considers as one of the priorities of its activity.
During the visit, representatives of both sides exchanged views on improving cooperation and discussed a plan for further actions.
“I am very pleased to visit Darnytsia. I saw with my own eyes how efficiently the company works despite the horrors of war. I express my support for the staff of Darnytsia and the entire Ukrainian people. I sincerely wish hardiness and I will be happy to contribute to the expansion of cooperation so that Darnytsia medicines are available in Iraq,” the Chargé d’Affaires a.i. of the Republic of Iraq to Ukraine, Minister Plenipotentiary Mr. Tarek Adil Kazem said.
“We are always happy to welcome honorable guests to Darnytsia. I am grateful to Mr. Tarek for taking the time to visit our company and for his positive assessment of our work. I am convinced that our cooperation will bring fruitful results for both sides,” Andrii Obrizan, the CEO of Darnytsia Pharmaceutical Company, added.